Endo International is a holding company that focused on branded and generic pharmaceuticals. Co.'s segments are: Branded Pharmaceuticals, which includes branded prescription products to treat and manage conditions in urology, urologic oncology, endocrinology, pain and orthopedics; Sterile Injectables, which consists of branded sterile injectable products; Generic Pharmaceuticals, which includes products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, and women's health, among others; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder. The ENDP stock yearly return is shown above.
The yearly return on the ENDP stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the ENDP annual return calculation with any dividends reinvested as applicable (on ex-dates).
|